Tabogab NT 75mg/10mg Tablet
Marketer
Albia Biocare
Salt Composition
Pregabalin (75mg) + Nortriptyline (10mg)
Overview Tabogab NT 75mg/10mg Tablet
Neuropathic pain is treated with the combined medication, Nervecalm 75mg/10mg tablets. This medication alleviates pain by interrupting the transmission of pain signals to the central nervous system. Nervecalm 75mg/10mg tablets are administered orally, with or without food, ideally before sleep. Consistent daily timing helps ensure stable blood levels. Follow your physician's prescribed dosage and duration; this medication can be habit-forming. If a dose is missed, take it immediately upon recollection. Complete the entire course, even with symptom improvement. Abrupt cessation should only occur under medical supervision. Common side effects include urinary difficulty, constipation, weight gain, fatigue, and dry mouth. Dizziness and drowsiness may also occur, so avoid activities demanding concentration until the medication's effects are understood. Weight gain is possible; regular exercise and a balanced diet can help mitigate this. Report any unusual mood shifts, new or worsening depression, or suicidal ideation to your doctor immediately. Prior to commencing treatment, disclose any kidney or liver conditions, and list all other medications, as interactions may reduce efficacy or alter the medication's action. Inform your doctor of pregnancy, pregnancy plans, or breastfeeding.
Uses of Tabogab NT 75mg/10mg Tablet
Managing neuropathic pain
Major Benefits of Tabogab NT 75mg/10mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the 75mg/10mg Tabogab NT tablet whole; avoid chewing, crushing, or breaking it. Consumption may coincide with meals or not, though consistent timing is recommended.
Common Side effects of Tabogab NT 75mg/10mg Tablet:
- Dryness in mouth
- Increased heart rate
- Sleepiness
- Dizziness
- Tiredness
- Weight gain
- Blurred vision
- Orthostatic hypotension (sudden lowering of blood pressure on standing)
- Uncoordinated body movements
- Increased appetite
- Increased libido
- Paresthesia (tingling or pricking sensation)
- Vertigo
- Vomiting
- Nausea
- Erectile dysfunction
- Joint pain
- Constipation
- Difficulty in urination
How to use Tabogab NT 75mg/10mg Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the 75mg/10mg Tabogab NT tablet whole; avoid chewing, crushing, or fracturing it. This medication can be administered with or without food, although consistent daily timing is recommended.
How Tabogab NT 75mg/10mg Tablet works:
Tabogab NT 75mg/10mg tablets contain pregabalin and nortriptyline, working synergistically to manage neuropathic pain. Pregabalin, an alpha-2-delta ligand, reduces pain by modulating nerve cell calcium channel activity. Nortriptyline, a tricyclic antidepressant, elevates serotonin and noradrenaline levels, thereby inhibiting pain signal transmission in the brain. This dual mechanism provides effective relief from nerve damage-induced pain.
SAFETY ADVICE
AlcoholUNSAFE
Concomitant use of Tabogab NT 75mg/10mg tablets and alcohol can induce significant drowsiness.
PregnancyCONSULT YOUR DOCTOR
Use of Tabogab NT 75mg/10mg tablets during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Tabogab NT 75mg/10mg tablets while breastfeeding is likely inadvisable. Preliminary data in humans indicates potential transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by Tabogab NT 75mg/10mg Tablets, due to potential side effects that can reduce alertness.
KidneyCAUTION
Individuals with impaired kidney function should exercise caution when using Tabogab NT 75mg/10mg tablets. Dosage modification may be necessary. A physician's consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Tabogab NT 75mg/10mg tablets in individuals with hepatic impairment is likely safe. Current evidence indicates dose modification may be unnecessary, however, medical advice is recommended.
What if you forget to take Tabogab NT 75mg/10mg Tablet :
Should you forget to take a Tabogab NT 75mg/10mg Tablet, administer it at your earliest convenience. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Tabogab NT 75mg/10mg Tablet
| Label | Value |
|---|---|
| Addictive | None. |
| Medication Classification | Central Nervous System (CNS) medications |
FAQs on Tabogab NT 75mg/10mg Tablet
The combined medication Tabogab NT 75mg/10mg Tablet, containing Pregabalin and Nortriptyline, provides relief from nerve pain (neuropathic pain). Its mechanism involves central nervous system action, modulating the activity of damaged or overly sensitive nerves to reduce pain perception.
Discontinuing Tabogab NT 75mg/10mg Tablet, even with pain relief, is inadvisable. Follow your physician's prescribed regimen. Abrupt cessation may trigger withdrawal effects including anxiety, insomnia, nausea, pain recurrence, and diaphoresis. A gradual dose reduction is recommended prior to complete discontinuation.
Taking Tabogab NT 75mg/10mg tablets may increase appetite, potentially leading to weight gain. Preventing weight gain is simpler than subsequent weight loss. Maintain a balanced diet without enlarging portions. Avoid high-calorie foods like sugary drinks, fried foods, crisps, pastries, and confectionery. Between meals, choose fruits, vegetables, and low-calorie options instead of snacks. Regular physical activity will help prevent weight gain. Consistent healthy eating and exercise may prevent any weight increase.
Tabogab NT 75mg/10mg Tablets can induce drowsiness, potentially causing sudden sleep onset during routine tasks. This may occur without prior warning signs such as drowsiness. Refrain from driving, operating equipment, working at heights, or engaging in hazardous activities, especially at the treatment's outset, until the medication's effects are understood. Report any such incidents to your physician.
Taking Tabogab NT 75mg/10mg Tablets may impact sexual function in both males and females. Reported side effects include reduced libido, erectile dysfunction (difficulty achieving or sustaining an erection), and anorgasmia (inability to reach orgasm). Decreased sexual satisfaction and discomfort during intercourse are also possible. Should these issues arise, consult your physician; however, do not discontinue Tabogab NT 75mg/10mg Tablet use without medical advice.
Adverse reactions to Tabogab NT 75mg/10mg tablets are infrequent and seldom reported. Seek immediate medical advice if you experience: altered body temperature, respiratory distress, rapid heartbeat (palpitations), fatigue, gait instability, impaired coordination or sluggish responses, atypical mood or behavioral shifts (including agitation, anxiety, or euphoria), depressive symptoms, hallucinations (auditory or visual), delusional thinking, visual disturbances (blurred or double vision), involuntary eye movements (nystagmus), visual impairment, or indications of recurrent infections like fever, rigors, pharyngitis, or oral ulcers. While uncommon, these reactions warrant prompt medical intervention.
Patients may experience initial improvements with Tabogab NT 75mg/10mg Tablets within two weeks. Complete therapeutic effects, however, typically manifest within two to three months. For some individuals, achieving optimal results may require a longer treatment duration.
Should you miss a scheduled dose of Tabogab NT 75mg/10mg Tablet, and your next dose is imminent, omit the missed dose and proceed with your regular schedule. If sufficient time remains before your next dose, take the medication immediately upon recollection and then resume your usual dosing regimen. Avoid doubling your dose to compensate for a missed one; this may heighten the likelihood of adverse reactions from an overdose. When in doubt regarding the appropriate course of action, seek guidance from your physician.
If this occurs, promptly contact your physician or proceed to the closest emergency room. Seek medical assistance regardless of the presence or absence of symptoms. Immediate care may be necessary. Overdose symptoms can manifest as lethargy, fatigue, gait instability, diplopia, dysarthria, diarrhea, disorientation, blurred vision, vertigo, fluctuating body temperature, respiratory distress, and tachycardia.
Increasing the prescribed dosage won't necessarily improve results; instead, it could heighten the risk of severe adverse reactions and harmful effects. Should your symptoms worsen despite adhering to the recommended dosage, seek medical advice for reassessment.
Taking Tabogab NT 75mg/10mg Tablets may affect cognitive function and reflexes. Drive cautiously and avoid activities demanding alertness. Alcohol consumption should be avoided during treatment, as it can intensify the drug's effects, potentially causing harm. Grapefruit and its juice may interact adversely; their use should be avoided. Increased sun sensitivity is a possible side effect; limit sun exposure and use protective clothing and sunscreen while outdoors.
Regular check-ups with your physician may be necessary following commencement of Tabogab NT 75mg/10mg Tablet therapy. Consult your doctor immediately if your symptoms persist or worsen despite the prescribed dosage, or if you experience adverse effects impacting your daily life.
Retain the medication within its original packaging until needed. Store in a cool, dry location, inaccessible to children. Proper disposal of any remaining medicine is crucial to prevent accidental ingestion by children, pets, or others.
The combined medication Tabogab NT 75mg/10mg Tablet, containing Pregabalin and Nortriptyline, offers relief from nerve pain (neuropathic pain). Its mechanism involves central nervous system action, soothing irritated or hyperactive nerves and consequently reducing pain perception.
Discontinuing Tabogab NT 75mg/10mg Tablet, even with pain relief, is inadvisable. Follow your physician's prescribed regimen. Abrupt cessation may trigger withdrawal effects including anxiety, insomnia, nausea, pain recurrence, and diaphoresis. A gradual dose reduction is recommended prior to complete discontinuation.
Taking Tabogab NT 75mg/10mg tablets may increase appetite, potentially leading to weight gain. Weight maintenance is simpler than weight loss. Maintain a balanced diet without enlarging portions. Avoid high-calorie foods like sugary drinks, fried foods, processed snacks, and desserts. Between meals, opt for fruits, vegetables, and low-calorie options instead of junk food. Regular physical activity will help prevent weight gain. A healthy diet and exercise routine can minimize weight increase.
Using Tabogab NT 75mg/10mg Tablets may cause drowsiness or sudden sleep onset during routine activities. This sleepiness may occur without warning. Refrain from driving, operating equipment, working at heights, or engaging in hazardous tasks initially, until the medication's effects are understood. Report any such incidents to your physician.
Taking Tabogab NT 75mg/10mg Tablets may impact sexual function in both genders. Reduced libido, erectile dysfunction (difficulty achieving or sustaining an erection), and anorgasmia are frequently reported side effects. Decreased sexual satisfaction and discomfort during intercourse may also occur. Consult your physician if you experience these issues; however, do not discontinue Tabogab NT 75mg/10mg Tablets without medical advice.
Adverse reactions to Tabogab NT 75mg/10mg tablets are infrequent and seldom reported. Seek immediate medical advice if you experience: altered body temperature, respiratory distress, rapid heartbeat, fatigue, gait instability, impaired coordination or delayed reflexes, atypical mood or behavioral shifts (including agitation, anxiety, or exhilaration), depressive symptoms, hallucinations, disordered thinking, visual disturbances (blurred or double vision), involuntary eye movements, visual impairment, or indicators of recurrent infections like fever, intense chills, pharyngitis, or oral ulcers. While uncommon, these reactions warrant prompt medical intervention.
Patients may experience initial improvements with Tabogab NT 75mg/10mg Tablets within two weeks, though complete therapeutic effects typically manifest after two to three months. In some cases, a longer treatment duration may be necessary.
Should you miss a dose of Tabogab NT 75mg/10mg Tablet, and your next dose is nearly due, omit the missed dose and continue with your regular schedule. If your next dose is not imminent, take the medication as soon as you recall, then resume your usual dosing pattern. Avoid doubling up on doses to compensate for a missed one; this could heighten the chance of adverse reactions from an overdose. For any uncertainty regarding missed doses, seek guidance from your physician.
Should this occur, promptly contact your physician or present yourself to the closest emergency room. Seek medical assistance regardless of the presence or absence of symptoms. Immediate medical intervention may be necessary. Overdose symptoms can manifest as lethargy, fatigue, gait instability, diplopia, dysarthria, diarrhea, disorientation, blurred vision, vertigo, fluctuating body temperature, respiratory distress, and tachycardia.
Exceeding the prescribed dosage won't necessarily improve outcomes; instead, it heightens the risk of severe adverse reactions and potential poisoning. If your symptoms worsen despite adhering to the recommended dosage, seek medical advice for reassessment.
Taking Tabogab NT 75mg/10mg tablets may reduce alertness and impair cognitive function. Driving or operating machinery should be avoided until the effects of the medication are known. Alcohol consumption should be ceased while using Tabogab NT 75mg/10mg tablets due to the potential for dangerously amplified effects. Grapefruit and its juice can interact negatively with this medication, possibly leading to adverse reactions. Increased sun sensitivity is a potential side effect; therefore, sun exposure and tanning beds should be avoided. Protective clothing and sunscreen are recommended when outdoors during daylight hours.
Regular check-ups with your physician may be necessary following initiation of Tabogab NT 75mg/10mg Tablet therapy. Consult your doctor immediately if your symptoms don't improve with the prescribed Tabogab NT 75mg/10mg Tablet dosage, or if adverse effects interfere with your daily life.
Retain the medication within its original packaging until needed. Maintain storage in a cool, dry location. Keep the medication out of the view and access of children. Unneeded medication requires proper disposal to prevent accidental ingestion by children, pets, or others.
Pregabalin and Nortriptyline, combined as Tabogab NT 75mg/10mg Tablet, provide relief from nerve pain (neuropathic pain). The medication's action on the brain soothes damaged or excessively active nerves, consequently reducing pain perception.
Discontinuing Tabogab NT 75mg/10mg Tablet, even with pain relief, is inadvisable. Follow your physician's prescribed regimen. Abrupt cessation may lead to withdrawal effects including anxiety, insomnia, nausea, pain recurrence, and diaphoresis. A gradual dosage reduction is recommended prior to complete discontinuation.
Consuming Tabogab NT 75mg/10mg Tablets may increase appetite, potentially leading to weight gain. Weight management is simpler than weight loss. Maintain a nutritious, balanced diet without enlarging meal portions. Limit high-calorie foods like sugary drinks, fried items, processed snacks, and desserts. Between meals, opt for fruits, vegetables, and low-calorie options instead of junk food. Regular physical activity aids in preventing weight gain. Consistent healthy eating and exercise may preclude weight increase.
Tabogab NT 75mg/10mg Tablets can cause drowsiness and sudden sleep onset during normal daily routines. This may occur without prior warning signs. Refrain from driving, operating equipment, working at heights, or engaging in hazardous activities initially, until the medication's effects are understood. Report any such incidents to your physician.
Taking Tabogab NT 75mg/10mg tablets may impact sexual function in both genders. Reduced libido, erectile dysfunction (difficulty achieving or sustaining an erection), and anorgasmia are frequently reported. Decreased sexual satisfaction and discomfort during intercourse may also occur. Consult your physician if these side effects arise, but do not discontinue Tabogab NT 75mg/10mg tablets without medical advice.
Rarely, Tabogab NT 75mg/10mg Tablets may cause serious adverse reactions. Seek immediate medical advice if you experience: altered body temperature, respiratory distress, rapid heartbeat, fatigue, gait instability, impaired coordination or reflexes, unusual mood or behavioral shifts (including agitation, anxiety, or euphoria), depressive symptoms, hallucinations, disordered thought processes, visual disturbances (blurred or double vision, involuntary eye movements, impaired vision), or symptoms suggesting frequent infections like fever, intense chills, pharyngitis, or oral ulcers. While infrequent, these reactions necessitate prompt medical intervention.
Observable improvements with Tabogab NT 75mg/10mg tablets might begin after a fortnight of therapy. Complete therapeutic effects, however, typically manifest within two to three months. For certain individuals, a longer timeframe may be necessary.
Should you miss a scheduled dose of Tabogab NT 75mg/10mg Tablet, and your next dose is imminent, omit the missed dose and proceed with your regular schedule. If your next dose is not soon, take the missed dose immediately upon remembering, then resume your usual medication regimen. Avoid doubling up on doses to compensate for a missed one, as this elevates the risk of adverse reactions from an overdose. In case of uncertainty, seek guidance from your physician regarding appropriate action.
If this occurs, promptly contact your physician or proceed to the nearest emergency room. Seek medical assistance regardless of the presence or absence of symptoms. Immediate medical care may be necessary. Overdose symptoms can manifest as sleepiness, fatigue, gait instability, diplopia, dysarthria, diarrhea, disorientation, visual blurring, vertigo, fluctuating body temperature, respiratory distress, and tachycardia.
Increasing your medication dosage beyond the prescribed amount won't necessarily improve its effectiveness; instead, it could heighten the risk of severe adverse reactions and harmful effects. Should your symptoms worsen despite adhering to the recommended dosage, seek a physician's assessment for further evaluation.
Taking Tabogab NT 75mg/10mg Tablets may reduce alertness and impair cognitive function. Driving or operating machinery should be avoided until the effects of the medication are known. Alcohol consumption is contraindicated during treatment with Tabogab NT 75mg/10mg Tablets as it may potentiate adverse effects. Grapefruit and grapefruit juice should be avoided due to potential drug interactions. Increased sun sensitivity is a potential side effect; protective clothing and sunscreen are recommended during daylight hours to prevent sunburn.
Regular check-ups with your physician may be necessary following the commencement of Tabogab NT 75mg/10mg Tablet treatment. Consult your doctor immediately if your symptoms persist or worsen despite taking the prescribed dose, or if you experience adverse effects impacting your daily life.
Protect your medication by leaving it in its original packaging until needed. Store the tablets in a cool, dry location, inaccessible to children. Proper disposal of any leftover medication is crucial to prevent accidental ingestion by children, pets, or others.
3,018 People bought this recently
Tabogab NT 75mg/10mg Tabl...
98
MRP 120
18% off